Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

García-Moguel I, Agüero Calvo J, Betancor Pérez D, Carretero Gracia JÁ, Díaz-Campos RM, Fernández Martínez de Septien C, Gómez-Bastero Fernández A, Hernández Galván Y, Lloret-Queraltó JA, Lluch Tortajada I, Malanda NM, Martín-García C, Martínez Mesa Á, Martínez-Moragon E, Medina Gallardo JF, Padilla-Galo A, Pérez Chica G, Plasencia García I, Prieto Montaño P, Puchaes Manchón C, Romero Ribate D, Valverde-Monge M, Zamarro Parra MS, Sanchez-Trincado JL, Nuevo J, Luzon E, Velasco-Garrido JL

Open source

DOI
10.3390/jcm15124564
Published
2026 Jun 12
Container
Journal of clinical medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15124564,
  title = {Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.},
  author = {García-Moguel I and Agüero Calvo J and Betancor Pérez D and Carretero Gracia JÁ and Díaz-Campos RM and Fernández Martínez de Septien C and Gómez-Bastero Fernández A and Hernández Galván Y and Lloret-Queraltó JA and Lluch Tortajada I and Malanda NM and Martín-García C and Martínez Mesa Á and Martínez-Moragon E and Medina Gallardo JF and Padilla-Galo A and Pérez Chica G and Plasencia García I and Prieto Montaño P and Puchaes Manchón C and Romero Ribate D and Valverde-Monge M and Zamarro Parra MS and Sanchez-Trincado JL and Nuevo J and Luzon E and Velasco-Garrido JL},
  year = {2026},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm15124564},
  url = {https://doi.org/10.3390/jcm15124564}
}

RIS

TY  - JOUR
TI  - Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.
AU  - García-Moguel I
AU  - Agüero Calvo J
AU  - Betancor Pérez D
AU  - Carretero Gracia JÁ
AU  - Díaz-Campos RM
AU  - Fernández Martínez de Septien C
AU  - Gómez-Bastero Fernández A
AU  - Hernández Galván Y
AU  - Lloret-Queraltó JA
AU  - Lluch Tortajada I
AU  - Malanda NM
AU  - Martín-García C
AU  - Martínez Mesa Á
AU  - Martínez-Moragon E
AU  - Medina Gallardo JF
AU  - Padilla-Galo A
AU  - Pérez Chica G
AU  - Plasencia García I
AU  - Prieto Montaño P
AU  - Puchaes Manchón C
AU  - Romero Ribate D
AU  - Valverde-Monge M
AU  - Zamarro Parra MS
AU  - Sanchez-Trincado JL
AU  - Nuevo J
AU  - Luzon E
AU  - Velasco-Garrido JL
PY  - 2026
JO  - Journal of clinical medicine
DO  - 10.3390/jcm15124564
UR  - https://doi.org/10.3390/jcm15124564
ER  - 

APA

I, G., J, A. C., D, B. P., JÁ, C. G., RM, D., C, F. M. D. S., A, G. F., Y, H. G., JA, L., I, L. T., NM, M., C, M., Á, M. M., E, M., JF, M. G., A, P., G, P. C., I, P. G., P, P. M., C, P. M., D, R. R., M, V., MS, Z. P., JL, S., J, N., E, L., & JL, V. (2026). Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.. Journal of clinical medicine. https://doi.org/10.3390/jcm15124564

Source records